Australia's largest stock trading and investment forum Australia's #1 stock forum

CF1

10.0%

2.2¢ complii fintech solutions ltd

MOU2 and MOU3, page-88

First 88 Last

Share
Profile

Follow
malmanu

16,462 Posts.

774

04/02/17

17:55

Post #: 22373882
Share

Originally posted by malmanu ↑

What does it really matter Mou 2,3,4,5,6,7,8,9 , it still doesn't justify the current 95m market cap ( shares plus options well in the money , not including the 500m performance shares )

250m performance shares are issued if IAM achieves aggravated net profit after tax of $1m by jun2019 and another 250m performance shares if IAM achieves aggravated net profit after tax of $4m by jun2019.

I think they will achieve aggravated net profit after tax of $1m by jun2019 but not sure about achieving aggravated net profit after tax of $4m by jun2019 . So if another 250m shares get issued in say 2018/19 it puts the market cap up to $111m at 6.4c. I think current fair value for IAM should be somewhere around $30m to $40m until we see revenue and advice firm growth.

Look at one of their competitors , VBP Back Office Solutions who are expanding fast , they now have 55 advice firms as clients , up 83% from a year ago. Will IAM offer a better deal and service than VBP Back Office Solutions.

See VBP Year in Review 2016 video at https://www.facebook.com/vbpbackofficesolutions

Expand

Meant to say aggregated instead of aggravated but some will see my post as aggravated anyway.

IAM Price at posting: 6.4¢ Sentiment: Sell Disclosure: Not Held
7 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 635 more messages in this thread...

First 88 Last

Add CF1 (ASX) to my watchlist

(20min delay)
Last 2.2¢		Change 0.002(10.0%)		Mkt cap ! $12.58M

Open	High	Low	Value	Volume
2.1¢	2.2¢	2.1¢	$7.78K	360.6K

Buyers (Bids)

No.	Vol.	Price($)
1	103090	2.2¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	300000	1

View Market Depth

No.	Vol.	Price($)
1	491617	0.020
1	200000	0.019
3	1434231	0.018
1	1000000	0.017
1	1000000	0.016

Price($)	Vol.	No.
0.023	300000	1
0.024	125000	1
0.026	64744	1
0.028	483161	1
0.030	827135	4

Last trade - 15.54pm 04/10/2024 (20 minute delay)

CF1 (ASX) Chart

MOU2 and MOU3, page-88

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

MOU2 and MOU3, page-88

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News